Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-29

Clinical Trial Update: Post Marketing Observational Study on Venezuelan Patients With Psoriasis

View source ↗

Summary

A post-marketing observational study in Venezuelan patients with chronic plaque psoriasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Status: WITHDRAWN